Oral fluid drug testing is a simple and effective resource for our clients to gain insight into a patient’s medication usage. Oral fluid testing can verify whether patients are taking prescribed medications as directed by a physician, refraining from use of illicit and non-prescribed medications, and complying with the rules of a treatment plan or mandated abstinence.
An additional substantial benefit of oral fluid analysis at Cordant Health Solutions™ is our low cutoff level for buprenorphine (a major ingredient in Suboxone). This makes oral fluid an ideal test method for use in addiction treatment. Cordant can test for an extensive number of analytes via oral fluid to identify commonly prescribed medications and illicit drugs.
Oral fluid analysis is particularly well suited for treating patients who are on chronic pain therapy with use of controlled substances (such as opioids), who are at high risk, or who have engaged in aberrant drug-related behavior such as sample tampering. This testing method can verify that patients are refraining from illicit and non-prescribed medications and complying with the treatment plan or treatment agreement. Oral fluid drug testing can highlight potentially harmful drug-to-drug interactions and inconsistencies so physicians can adjust their patients’ medication to better manage their chronic pain.
Oral fluid can be collected in a public setting, which eliminates concerns of specimen adulteration or substitution.
Specimens can be collected without infringing on patient privacy and without the need for special facilities or personnel.
Quantitative oral fluid drug analysis provides better estimated plasma concentration of a drug compared to urine.
With a detection window of up to 36 hours, oral fluid offers a significant advantage in identifying recent drug use.
Oral fluid testing primarily detects compounds of the parent drug, whereas urine can detect only the drug’s metabolites.